Legal Opinion
In Re Rezulin Products Liability Litigation
District Court, S.D. New York
Decided December 20, 2001No. 00 Civ 2843 LAKPublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
KAPLAN, District Judge.
Sherwyn Schwartz and Philip Raskin, medical doctors resident in Texas who participated in clinical trials of Rezulin, the drug at issue in this litigation, move to quash subpoenas that seek to compel them to produce medical records pertaining to certain patients who were subjects of those trials. Plaintiffs, who issued the subpoenas, are not interested in the identities of or identifying information concerning the subjects and are amenable to the redaction of the documents to remove that information and to affording confidential treatment to the…
2Cases cited18 opinions
- West v. American Telephone & Telegraph Co.Supreme Court of the United States · 1940
- Hicks Ex Rel. Feiock v. FeiockSupreme Court of the United States · 1988
- The Travelers Insurance Company v. 633 Third AssociatesCourt of Appeals for the Second Circuit · 1994
- R.K. v. RamirezTexas Supreme Court · 1994
- Parkson v. Central DuPage HospitalAppellate Court of Illinois · 1982
13 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- In re Zyprexa Products Liability LitigationDistrict Court, E.D. New York · 2008
- Staley v. NORTHERN UTAH HEALTHCAREUtah Supreme Court · 2010
- Wipf v. AltstielSouth Dakota Supreme Court · 2016
- In re Zyprexa Products Liability LitigationDistrict Court, E.D. New York · 2009
- Wipf v. AltstielSouth Dakota Supreme Court · 2016